AQST - Aquestive Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5123.63M
Enterprise Value 3127.79M
Trailing P/E N/A
Forward P/E 1-2.72
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.18
Price/Book (mrq)N/A
Enterprise Value/Revenue 32.26
Enterprise Value/EBITDA 6-1.99

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -141.54%
Operating Margin (ttm)-118.80%

Management Effectiveness

Return on Assets (ttm)-73.77%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)56.66M
Revenue Per Share (ttm)2.44
Quarterly Revenue Growth (yoy)-46.00%
Gross Profit (ttm)46.44M
EBITDA -64.15M
Net Income Avi to Common (ttm)-80.2M
Diluted EPS (ttm)-3.4570
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)39.93M
Total Cash Per Share (mrq)1.6
Total Debt (mrq)47.59M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.89
Book Value Per Share (mrq)-0.24

Cash Flow Statement

Operating Cash Flow (ttm)-31.46M
Levered Free Cash Flow (ttm)-6.31M

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 35.75%
52 Week High 320.6960
52 Week Low 33.6500
50-Day Moving Average 34.6491
200-Day Moving Average 36.3246

Share Statistics

Avg Vol (3 month) 3109.1k
Avg Vol (10 day) 3126.3k
Shares Outstanding 524.98M
Float 17.44M
% Held by Insiders 123.88%
% Held by Institutions 166.50%
Shares Short (May 31, 2019) 4606.42k
Short Ratio (May 31, 2019) 45.04
Short % of Float (May 31, 2019) 45.43%
Short % of Shares Outstanding (May 31, 2019) 42.43%
Shares Short (prior month Apr 30, 2019) 4393.23k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A